|
|
||||||||
|
FIGURE 3. (A) Yearly loss in CLR >20% (black bars) and <20% (white bars) in 28 patients treated with 90Y-DOTATOC who had 04 risk factors from hypertension, diabetes, age >60 y, and maximal per-cycle renal radiation dose >14 Gy. (B) Yearly loss in CLR >20% and <20% in 65 patients treated with 90Y-DOTATOC or 177Lu-DOTATATE who had 05 risk factors from hypertension, diabetes, age >60 y, cumulative renal radiation dose, and maximal per cycle radiation dose.
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY | THE JOURNAL OF NUCLEAR MEDICINE |